07:00 , Apr 30, 2007 |  BC Week In Review  |  Company News

BioLife Solutions Inc., J&J deal

JNJ’s Centocor Research and Development Inc. subsidiary received a non-exclusive license to BLFS’s CryoStor Dlite reduced DMSO cryopreservation media. Centocor uses CryoStor Dlite in the production of undisclosed cell therapy candidates. Financial terms were not...
07:00 , Jul 10, 2000 |  BC Week In Review  |  Company News

Cryomedical Sciences Inc. other research news

CRYM's BioLife Solutions Inc. subsidiary received a $94,000 Phase I SBIR grant from the National Center for Research Resources to study how apoptosis-inducing cancer therapeutics increase the efficacy of cryoablation. CRYM said the data will...